Christopher McCarthy insider trades
Open-market stock purchases and sales by Christopher McCarthy, CFO & COO at Interpace Biosciences, Inc, from SEC Form 4 filings since Jul 31, 2023.
Recent trades
Companies traded
- IDXG Interpace Biosciences, Inc: other filings, last Aug 20, 2026
Get free alerts when Christopher McCarthy files a new trade →